82.56 <%= Resources.Global.txtDown %>
Updated 18/05/2018
Change % -0.15% Stock price decreasing
Change -0.12 Stock price decreasing
Volume 271,843
High 83.18
Low 82.26
Open 82.78
ISIN BE0003818359
Prev close 82.68
# of shares 51.24M
Market cap 4,229.96M EUR

Market closed
Market is closed, opens at 08:00
Price development Latest 1 week 1 month 3 months 6 months 1 year
  82.56 3.6% Stock price increasing 4.6% Stock price increasing -12.8% Stock price decreasing 4.1% Stock price increasing 7.0% Stock price increasing
Powered by TradingView

News about Galapagos

  • English
  • Regulatory news

Company profile

Galapagos is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
21 May 2018 01:57:32
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180515.2 - EUROWEB5 - 2018-05-21 02:57:32 - 2018-05-21 01:57:32 - 1000 - Website: OKAY